| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.021 | 0.7 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.025 | 0.7 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.047 | 0.4 |